Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Omer Jamy
Assistant Professor
Close
E-mail
ojamy@uab.edu
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Omer Jamy
Assistant Professor
Positions
Associate Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Associate Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
2019 -
Assistant Professor (P)
,
Medicine - Hematology & Oncology
,
Department of Medicine
2019 -
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2021
Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation
.
Bone Marrow Transplantation
.
2021
2020
Usefulness of patient-reported outcomes to assess the effectiveness of topical hormonal therapy for gynecologic symptoms after antihormonal treatment for breast cancer
.
Baylor University Medical Center Proceedings
. 33:331-335.
2020
2020
Observation Versus Immediate Reinduction for Acute Myeloid Leukemia Patients With Indeterminate Day 14 Bone Marrow Results
.
Clinical Lymphoma, Myeloma and Leukemia
. 20:31-38.
2020
2019
Acute promyelocytic leukemia during pregnancy: A case report and 10-year institutional review of hematologic malignancies during pregnancy
2019
2019
Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors
.
Leukemia Research
. 82:1-6.
2019
2018
Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow
.
Leukemia Research
. 74:64-67.
2018
2017
Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline
.
Expert Opinion on Emerging Drugs
. 22:347-355.
2017
2016
Under-recognition of hemophagocytic syndrome in United States’ rural, non-teaching hospitals
2016
2016
Genomic alterations in neuroendocrine cancers of the ovary
.
Journal of Ovarian Research
. 9.
2016
2016
Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome
.
Clinical Lymphoma, Myeloma and Leukemia
. 16:230-236.
2016
2015
Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis
.
Leukemia Research
. 39:1342-1346.
2015
2015
How center volumes affect early outcomes in acute myeloid leukemia
.
Clinical Lymphoma, Myeloma and Leukemia
. 15:646-654.
2015
2015
Induction of acute myeloid leukemia with idarubicin, cytarabine and cladribine
2015
2015
Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemia
.
Clinical Lymphoma, Myeloma and Leukemia
. 15:364-367.
2015
2015
Male breast cancer: A 24 year experience of a tertiary care Hospital in Pakistan
2015
2015
Pleural epitheliod hemangioendothelioma: What started as a liver fluke and ended up being almost mistaken for malignant mesothelioma
.
Annals of Thoracic Medicine
. 10:289-291.
2015
2015
Population-based analysis of the clinical features of primary small cell carcinoma of the ovary
2015
2014
New oral anticoagulants in patients with atrial fibrillation (1)
2014
2013
Role of genetic counselling in prenatal diagnosis of β-thalassaemia in Pakistan.
2013
2011
Early complications after biliary enteric anastomosis for benign diseases: A retrospective analysis
.
BMC Surgery
. 11.
2011
2011
Clinical applications of the pedicled anterolateral thigh flap in penile reconstruction
2011
Research
Principal Investigator On
BMT CTN 1703/1801 A Randomized, Multicenter Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non Myeloablative / Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation and Companion Study: Microbiome and Immune Reconstitution in Cellular Therapies and Hematopoietic Stem Cell Transplantation (Mi-Immune)
awarded by
National Marrow Donor Program
2019 - 2025
Private Grant
awarded by
SELLAS LIFE SCIENCES GROUP, INC.
2020 - 2023
Private Grant
awarded by
CAREVIVE SYSTEMS, INC.
2019 - 2022
Investigator On
SWOG Purchase Services Agreement
awarded by
Oregon Health & Science University
2020 - 2025
Private Grant
awarded by
AMGEN, INC.
2020 - 2024
UAB 19113: A Phase 1 Study of NTX-301, an Oral DNMT1 Inhibitor, in Patients with MDS and AML
awarded by
SOUTHERN RESEARCH INSTITUTE
2020 - 2024
Private Grant
awarded by
INCYTE CORPORATION
2020 - 2024
Private Grant
awarded by
KARTOS THERAPEUTICS INC.
2019 - 2024
Private Grant
awarded by
KARTOS THERAPEUTICS INC.
2019 - 2024
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
2019 - 2024
Private Grant
awarded by
ASTEX PHARMACEUTICALS
2021 - 2024
Private Grant
awarded by
MARKER THERAPEUTICS INC
2021 - 2024
Private Grant
awarded by
ONCOIMMUNE, INC.
2020 - 2023
Private Grant
awarded by
FORTY SEVEN, INC.
2020 - 2023
Private Grant
awarded by
SEATTLE GENETICS, INC.
2020 - 2023
Private Grant
awarded by
AMGEN, INC.
2019 - 2023
Private Grant
awarded by
ABBVIE INC
2019 - 2023
Private Grant
awarded by
GlaxoSmithKline
2020 - 2022
Private Grant
awarded by
CTI BIOPHARMA CORP
2020 - 2022
Private Grant
awarded by
AVEO PHARMACEUTICALS, INC
2020 - 2022
Private Grant
awarded by
AMGEN, INC.
2018 - 2019
Background
Education And Training
Bachelor of Medicine & Surgery (MBBS),
Aga Khan University
2012
Contact
Full Name
Omer
Jamy